Filing Details
- Accession Number:
- 0000880771-16-000173
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-16 14:43:32
- Reporting Period:
- 2016-08-12
- Filing Date:
- 2016-08-16
- Accepted Time:
- 2016-08-16 14:43:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 880771 | Sciclone Pharmaceuticals Inc | SCLN | Pharmaceutical Preparations (2834) | 943116852 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1291656 | Wai-Shun Wilson Cheung | 950 Tower Lane, Suite 900 Foster City CA 94404 | Cfo & Senior Vp, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-08-12 | 25,000 | $0.00 | 25,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-08-12 | 12,500 | $0.00 | 37,500 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-08-12 | 3,000 | $0.00 | 40,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-08-12 | 9,396 | $10.41 | 31,104 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2016-08-12 | 1,128 | $10.41 | 29,976 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2016-08-12 | 4,698 | $10.41 | 25,278 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2016-08-16 | 7,802 | $10.62 | 17,476 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Acquisiton | 2016-08-12 | 30,000 | $0.00 | 30,000 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2016-08-12 | 25,000 | $0.00 | 25,000 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2016-08-12 | 12,500 | $0.00 | 12,500 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2016-08-12 | 3,000 | $0.00 | 3,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 229,000 | No | 4 | A | Direct | ||
| 204,000 | No | 4 | M | Direct | ||
| 191,500 | No | 4 | M | Direct | ||
| 188,500 | No | 4 | M | Direct |
Footnotes
- Shares disposed represent shares withheld to cover withholding tax obligations in connection with the vesting of Restricted Stock Units.
- Granted under the Issuer's 2015 Equity Incentive Plan.
- Each restricted stock unit represents the contingent right to receive one share of SciClone Pharmaceuticals, Inc.'s common stock.
- Each RSU will vest and be settled on August 15, 2017, subject to the reporting person's continued employment, but will terminate upon the occurrence of a change in control on or before March 31, 2017.
- Granted under the Issuer's 2005 Equity Incentive Plan.
- Provided Reporting Person remains employed by the Issuer, 33.33% of the restricted stock units vested on January 4, 2016, 33.33% will vest on January 3,2017, and 33.34% will vest on January 2, 2017, unless the trading window is closed for the Reporting Person on such date, in which case the vesting date will be deferred until the next date that the trading window is open.
- Provided Reporting Person remains employed by the Issuer, 25% of the restricted stock units will vest on each August 9, 2014, August 9, 2015, August 9, 2016, and August 9, 2017, unless the trading window is closed for the Reporting Person on such date, in which case the vesting date will be deferred until the next date that the trading window is open.
- Vesting for such RSUs will occur 25% on March 16, 2016, 25% on March 16, 2017, 25% on March 16, 2018, and 25% on March 16, 2019, or on such later date thereafter as the Company's trading window opens, if it is not open on any of such dates, contingent upon the executive's continued employment.
Billionaire Hedge Funds
